Viewing Study NCT01078961


Ignite Creation Date: 2025-12-24 @ 12:00 PM
Ignite Modification Date: 2025-12-27 @ 9:21 PM
Study NCT ID: NCT01078961
Status: COMPLETED
Last Update Posted: 2016-06-08
First Post: 2010-03-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
Sponsor: Massachusetts General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module